Belpointe Asset Management’s NEVRO CORP. NVRO Stock Holding History

Belpointe Asset Management’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-62	Closed	-$2.24K	–	3515
2023 Q1	$2.24K	Buy	+62	New	+$2.18K	﹤0.01%	3279

Other funds holding NVRO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Belpointe Asset Management's NVRO Position: Q2 2023 in Review

Belpointe Asset Management sold out of NEVRO CORP. (NVRO) in Q2 2023, closing a stake of 62 shares — an estimated $2.24K sold.

Belpointe Asset Management first reported a position in NVRO in Q1 2023 and held it in 1 quarter. The position peaked at $2.24K in Q1 2023. 155 funds tracked by Wall St. Rank hold NVRO as of Q2 2023.

Belpointe Asset Management reported no remaining NEVRO CORP. position as of Q2 2023 after selling out during the quarter.
Belpointe Asset Management sold 62 NEVRO CORP. shares in Q2 2023, an estimated $2.24K.
Belpointe Asset Management first reported a position in NEVRO CORP. in Q1 2023 and held it in 1 quarter.
Belpointe Asset Management's NEVRO CORP. position peaked at $2.24K in Q1 2023.
155 funds tracked by Wall St. Rank held NEVRO CORP. as of Q2 2023.

Based on Belpointe Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.